UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to_________ Commission file number: 001-01011 CVS HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 05-0494040 (State or ...

CVS Health on Wednesday reported fourth-quarter revenue and profit that topped estimates, even as its troubled insurance business continued to see higher medical costs. The company also issued a full-year 2025 adjusted earnings outlook of $5.75 to $6 per share, which was in line with Wall Street's expectations. But CVS did not provide a revenue forecast for the year. It caps off the first full quarter with David Joyner, a longtime CVS executive, as CEO of the troubled retail drugstore chain. Joyner succeede ...

Exhibit 99.1 CVS HEALTH CORPORATION REPORTS FOURTH QUARTER AND FULL-YEAR 2024 RESULTS Fourth Quarter Highlights Full-Year Highlights 2025 Full-Year Guidance CEO Commentary "Our integrated model allows us to uniquely deliver a simpler, connected experience that saves time, saves money, and improves health. We have continued to see growth in key areas of our business, including the Pharmacy and Consumer Wellness segment, while we address the industry-wide challenges that have impacted our Health Care Benefits ...

CVS Health reported more than $4.5 billion in 2024 profits including $1.6 billion in the fourth ... [+] quarter as the health insurer worked to overcome rising medical expenses from patients in its health insurance plans, the company said Feb. 12, 2025. In this photo is a sign marking the location of a CVS pharmacy May 5, 2004 in Chicago, Illinois. (Photo by Scott Olson/Getty Images)Getty ImagesCVS Health reported $4.6 billion in 2024 profits including $1.6 billion in the fourth quarter as the company worke ...

CVS Health Corp CVS will be reporting its fourth-quarter earnings on Wednesday. Wall Street expects 94 cents in EPS and $97.20 billion in revenues as the company reports before market hours.The stock is down 29.78% over the past year, up 22.72% YTD.Let’s look at what the charts indicate for CVS stock and how the stock currently maps against Wall Street estimates.Read Also: Wall Street’s Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend YieldsCVS Stock Chart Bullish Ahea ...

Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool recommends CVS Health. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool. ...

Analysts on Wall Street project that CVS Health (CVS) will announce quarterly earnings of $0.89 per share in its forthcoming report, representing a decline of 58% year over year. Revenues are projected to reach $97.06 billion, increasing 3.5% from the same quarter last year.The consensus EPS estimate for the quarter has been revised 1.3% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timefr ...

On Jan. 30, Walgreens Boots Alliance, a leading pharmacy chain, announced that it was suspending its dividend program, which had been active for over 90 years. This longtime dividend payer is suffering under the weight of financial troubles and had previously resorted to decreasing its payouts.Walgreens isn't the only dividend-paying pharmacy chain whose financial results haven't been strong recently. CVS Health (CVS -2.60%) is in the same boat. Should investors be worried about CVS also decreasing or endin ...

Value-focused billionaire asset managers are trading out pricey stocks for perceived-to-be safe, income-producing, brand-name businesses.For more than two years, the bulls have been running wild on Wall Street. Since 2023 began, the ageless Dow Jones Industrial Average, benchmark S&P 500 (^GSPC 0.72%), and growth-powered Nasdaq Composite have soared by 34%, 57%, and 88%, respectively, through the end of January 2025.While rising tides have given investors plenty of reason to smile, it's also made the stock ...

Volatility is plaguing Wall Street in light of President Donald Trump's tariffs. Regardless of what's up next, traders can take advantage of Schaeffer’s Senior Quantitative Analyst Rocky White's list of 25 worst S&P 500 Index (SPX) stocks for February to know which stocks to avoid over the coming weeks. CVS Health Corp (NYSE:CVS) is among them, and warrants a closer look.According to White, CVS averaged a 4.3% loss in February in the last decade, settling higher only three times during that period. The stoc ...